Skip to main content

UBS Group AG

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TRDA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$305,910
-$97,690 QoQ
Shares Held
41,564
+30.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 128 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. TRDA ranks #319 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $305,910 41,564
2026-03-31 $403,600 31,981
2025-12-31 $195,689 19,036
2025-09-30 $109,677 18,910
2025-06-30 $166,380 24,759
2025-03-31 $461,392 51,039
2024-12-31 $917,943 53,091
2024-09-30 $399,356 24,991
2024-06-30 $310,863 21,815
2024-03-31 $332,555 23,469
2023-12-31 $339,162 22,476
2023-09-30 $210,313 13,311
2023-06-30 $207,236 13,688
2023-03-31 $21,126 1,457
2022-12-31 $16,993 1,257
2022-06-30 $7,270 597
2022-03-31 $13,587 1,447
2021-12-31 $48,175 2,814